Cancers 2010, 2(2), 1040-1065; doi:10.3390/cancers2021040
Review

Biomarkers for Basal-like Breast Cancer

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
* Author to whom correspondence should be addressed.
Received: 19 March 2010; in revised form: 11 May 2010 / Accepted: 19 May 2010 / Published: 28 May 2010
(This article belongs to the Special Issue Biomarkers: Oncology Studies)
PDF Full-text Download PDF Full-Text [484 KB, uploaded 28 May 2010 15:38 CEST]
Abstract: Initially recognized through microarray-based gene expression profiling, basal-like breast cancer, for which we lack effective targeted therapies, is an aggressive form of carcinoma with a predilection for younger women. With some success, immunohistochemical studies have attempted to reproduce the expression profile classification of breast cancer through identification of subtype-specific biomarkers. This review aims to present an in depth summary and analysis of the current status of basal-like breast cancer biomarker research. While a number of biomarkers show promise for future clinical application, the next logical step is a comprehensive investigation of all biomarkers against a gene expression profile gold standard for breast cancer subtype assignment.
Keywords: breast cancer; basal-like; biomarkers; intrinsic subtype; immunohistochemistry; triple-negative; basaloid; expression profile

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Choo, J.R.; Nielsen, T.O. Biomarkers for Basal-like Breast Cancer. Cancers 2010, 2, 1040-1065.

AMA Style

Choo JR, Nielsen TO. Biomarkers for Basal-like Breast Cancer. Cancers. 2010; 2(2):1040-1065.

Chicago/Turabian Style

Choo, Jennifer R.; Nielsen, Torsten O. 2010. "Biomarkers for Basal-like Breast Cancer." Cancers 2, no. 2: 1040-1065.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert